📌 Key Takeaways
- Topic: What Is EMC Filler? Silica Fillers for Epoxy Molding Compounds Explained
- Keywords: semiconductor grade silica
- Published: 2026-11-20 03:37:11
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is the Common Name for Silicon Dioxide? Silica, Quartz and Other Names
- Silica Supplier UAE: How to Source Silica for the UAE and GCC Markets
- Schumacher, K., Grün, M. & Unger, K. Novel synthesis of spherical MCM-48. Micropor. Mesopor. Mater. 27, 201-206 (1999). Article CAS Google Scholar
- Silica for UV Adhesive: Rheology Control and Transparency Considerations
- Silica pH Value: Typical pH by Silica Type and Why It Matters
- Li, X. et al. Mesoporous silica nanobeans dual-functionalized with AIEgens and leaning pillararene-based supramolecular switches for imaging and stimuli-responsive drug release. Chem. Commun. 55, 14099-14102 (2019). Post CAS Google Scholar
- Silica as a Rheology Modifier: How It Controls Viscosity and Flow
- Among diverse metal oxide NPs/MSNs nanocomposites, the Fe 3 O 4 NPs with magnetic targeting, magnetic hyperthermia, enzyme-like activity or Fenton reaction activity are the most studied functional nanostructures. Importantly, MSNs can also play a different role in the applications of these nanocomposites. For example, MSNs that confine two different enzymes or enzyme mimics within the pore channel can be used as a nanoreactor for biomimetic cascade catalysis. 178, 179 Gao et al. encapsulated ultrasmall Au and Fe 3 O 4 NPs into the pores of dendritic MSNs for the construction of a tumor microenvironment-responsive nanocatalytic reactor. In the spatially isolated Au-based and Fe 3 O 4 -based reaction chamber, Au NPs exhibited unique glucose oxidase-like activity, catalyzing the conversion of glucose to gluconic acid and H 2 O 2, while the created H 2 O 2 was able to be used by the Fe 3 O 4 -based reaction chamber to boost the production of reactive oxygen species (ROS) by exhibiting peroxidase-like activity. 179 In addition, MSNs are an ideal nanotherapeutic platform that can achieve synergistic treatment of Fe 3 O 4 -mediated catalytic therapy with other therapeutic modalities including PTT, PDT, and chemotherapy, by loading other therapeutic agents. As reported by Li et al., they utilized organo-mesoporous silica to load the ultrasmall Fe 3 O 4 NPs and the photothermal agent Indocyanine Green (ICG). The photothermal effect caused by ICG could promote the Fenton reaction activity of Fe 3 O 4 NPs, thus achieving amplified intracellular oxidative stress. 180 Apart from, Sun et al. reported the construction of core-shelled Fe 3 O 4 @MSNs that encapsulated DOX and 3-amino-1,2,4-triazole (AT). The MSNs-based therapeutic nanoplatform can realize enhanced anti-tumor efficacy by releasing chemotherapeutic drugs for the enhanced catalytic generation of ROS. 181
Silica Matting Agent: How It Works, Key Specs and How to Choose the Right Grade
What is silica (SiO₂)?
silica rheology control He, Q., Shi, J., Zhu, M., Chen, Y. & Chen, F. The three-stage in vitro degradation behavior of mesoporous silica in simulated body fluid. Micropor. Mesopor. Mater. 131, 314-320 (2010). Piece CAS Google Scholar
What is the difference between fumed silica and precipitated silica?
custom silica Biomedical applications
What drives silica raw material prices?
porous silica MSNs-based scaffolds can enhance the cell proliferation, migration, adhesion and differentiation in bone tissue engineering. Many studies have systematically investigated and revealed the function of MSNs-based scaffolds in the regulation of cellular functions. 483, 484, 485, 486 Bone defects-involved regenerative mend is challenging to obtain a desired outcome due to the delay of early vascularization and poor osteogenic activity of bone implants. In this regard, researchers have designed a polycaprolactone network containing vascular-like structure, and introduced a nanofibrous gelatin-silica scaffold into it. Dimethyloxalylglycine (DMOG) and peptide-1 (BFP) were then loaded into MSNs, and the differential spatial distribution and sequential release of DMOG and BFP allowed the bioactive scaffold to promote angiogenesis by stimulating the migration of human umbilical vein endothelial cells (HUVECs), the tube formation and the expression of angiogenesis-related genes/proteins (HIF-1α, e-NOS, KDR and VEGF), as well as enhance osteogenesis by upregulating the expression of bone marrow-derived mesenchymal stem cells (BMSCs)-related osteogenic genes (Runx2, Col I, OPN and OCN) and promoting mineral matrix formation. 487 Apart from, Mora-Raimundo et al. reported MSNs as a nanocarrier to deliver SOST small interfering RNA (siRNA) and osteostatin, and the as-designed system could be used for osteoporosis remission via enhancing the bone microarchitecture. 379 Wang et al. designed a biomimetic silica-collagen scaffold via a robust biosilicification tactic, and the silica-collagen scaffold could mimic the distinctive microenvironment of bone extracellular matrix (ECM), resulting in the improvement of mesenchymal stem cell (MSC) recruitment and bone repair. 488 These MSNs-based scaffolds have excellent potential for clinical translation in the treatment of bone defects.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.